Thirteen years ago today, we began publishing Patent Docs, a weblog that initially focused on recent developments in biotech and pharma patent law, and has since expanded to cover all things patent-related. After thousands of posts and millions of words; after the claims-and-continuation rules debacle; the America Invents Act and all the bills that preceded it; the BPCIA from its enactment to recent interpretation by the courts; Bilski, Mayo, Myriad, Alice, Sequenom, and Athena; Ariad and KSR; Dudas, Rogan, Rea, Kappos, Lee, and Iancu, we have been blessed by our readers and patent law's seemingly inexhaustible number of interesting (and occasionally frustrating) things to write about. We look forward to the future, and having you all with us. Thanks for reading.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Supreme Court Denies Certiorari in Cellect v. Vidal
- In re Cellect in View of Supreme Court's "Long Conference" – Part II
- In re Cellect in View of Supreme Court's "Long Conference"
- Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc. (Fed. Cir. 2024)
- Astellas Pharma, Inc. v. Sandoz Inc. (Fed. Cir. 2024)
- Wisconsin Alumni Research Foundation v. Apple Inc. (Fed. Cir. 2024)
- Special Committee's Suspension Recommendation Adopted by Federal Circuit
- Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)
- Andersen v. Stability AI: Defendants' Motion to Dismiss Narrows the Case, But Only Slightly
- Ryan LLC v. FTC: Texas Federal Court Strikes Down FTC's Prohibition on Non-Competes
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Federal Circuit Invalidates Edison's Light Bulb Patent | Main | USPTO Issues Proposed Rules on Burden of Proof for Motions to Amend in Post-Grant Proceedings »
October 21, 2019
Comments
The comments to this entry are closed.
October 2024
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (277)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (104)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (26)
- District Court (222)
- Double Patenting (40)
- Enablement (52)
- Federal Circuit (1017)
- Food and Drug Administration (109)
- Hatch-Waxman (93)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (28)
- Infringement - Literal or DOE (91)
- Injunction (34)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (168)
- News from Abroad (102)
- Novelty (73)
- Obviousness (233)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (827)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (369)
- Patentable Subject Matter (644)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (7)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (88)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Happy Birthday! And keep up the good and valuable work - those of us fighting in the trenches benefit from your insights and concise analyses of often-baffling CAFC (and always-baffling SCOTUS) jurisprudence.
Posted by: James Demers | October 22, 2019 at 07:28 AM
Our pleasure; thanks so much for your valuable commentary, reportage, and insights.
Posted by: Kelly Morron | October 22, 2019 at 08:27 AM
Very hearty congratulations. Yours is an invaluable resource.
Posted by: Paul Cole | October 22, 2019 at 09:00 AM
Congratulations to Kevin, Donald, and all at patentdocs. I believe that 13 years for an online blog is 137 years in real time. The insights you've provided on court decisions and legislation has been very valuable. I remember covering IP conferences for other publications and the moderators would usually say, "And we have media here. Patentdocs is here"--which is a tribute to your influence. The best of luck for another 13 years--or another 137, whatever.
Posted by: John Aquino | October 22, 2019 at 09:23 AM
Congrats!
I can always count on a meaningful legal analysis of the topics that you cover.
While not being as "provocative" as other patent blog sources, the niche you serve is most appreciated!
Posted by: skeptical | October 22, 2019 at 03:40 PM
To the All Patent Docs:
Congratulations on the great work for these 13 years.
Posted by: EG | October 22, 2019 at 07:36 PM
Congrats and thanks for the great work!
Posted by: Fabricio | October 23, 2019 at 08:58 AM
Lucky 13. The substantial amount of work to exhaustively write-up virtually everything newsworthy in the patent arena is humbling. I'm grateful for the education and impressed by the diligence and scholarship displayed. Hope it rolls for many more years to come.
Posted by: Martin Snyder | October 23, 2019 at 12:58 PM
Congrats on 13 years of patiently and precisely elucidating an often shifting IP landscape.
Posted by: Kenton Mullins | November 02, 2019 at 09:38 PM